Terms: = Liver cancer AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1
245 results:
1. No Prognostic Impact of Graft-to-Recipient Weight Ratio on Hepatocellular Carcinoma Recurrence Following Living Donor liver Transplantation.
Yang G; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Park GC; Yoon YI; Kang WH; Joo SH; Lee SG
Ann Transplant; 2024 Mar; 29():e942767. PubMed ID: 38439530
[TBL] [Abstract] [Full Text] [Related]
2. Short-term postoperative outcomes of lymphadenectomy for cholangiocarcinoma, hepatocellular carcinoma and colorectal liver metastases in the modern era of liver surgery: Insights from the StuDoQ|liver registry.
Knitter S; Raschzok N; Hillebrandt KH; Benzing C; Moosburner S; Nevermann N; Haber P; Gül-Klein S; Fehrenbach U; Lurje G; Schöning W; Fangmann J; Glanemann M; Kalff JC; Mehrabi A; Michalski C; Reißfelder C; Schmeding M; Schnitzbauer AA; Stavrou GA; Werner J; Pratschke J; Krenzien F;
Eur J Surg Oncol; 2024 Apr; 50(4):108010. PubMed ID: 38394988
[TBL] [Abstract] [Full Text] [Related]
3. Glycogen metabolism-mediated intercellular communication in the tumor microenvironment influences liver cancer prognosis.
Zhang Y; Qin N; Wang X; Liang R; Liu Q; Geng R; Jiang T; Liu Y; Li J
Oncol Res; 2024; 32(3):563-576. PubMed ID: 38361757
[TBL] [Abstract] [Full Text] [Related]
4. A phase I study of atr inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours.
Burris HA; Berlin J; Arkenau T; Cote GM; Lolkema MP; Ferrer-Playan J; Kalapur A; Bolleddula J; Locatelli G; Goddemeier T; Gounaris I; de Bono J
Br J Cancer; 2024 Apr; 130(7):1131-1140. PubMed ID: 38287179
[TBL] [Abstract] [Full Text] [Related]
5. Exposure to Agent Orange and Hepatocellular Carcinoma Among US Military Personnel.
Benhammou JN; Leng M; Shah SC; Cholankeril G; Dong TS; Patel AA; Tong MJ
JAMA Netw Open; 2023 Dec; 6(12):e2346380. PubMed ID: 38048128
[TBL] [Abstract] [Full Text] [Related]
6. Programmable DNA Hydrogel Assisting Microcrystal Formulations for Sustained Locoregional Drug Delivery in Surgical Residual Tumor Lesions and Lymph Node Metastasis.
Zhang ZJ; Zhou Y; Tong H; Sun XC; Lv ZC; Yong JK; Wu YC; Xiang XL; Ding F; Zuo XL; Li F; Xia Q; Feng H; Fan CH
Adv Healthc Mater; 2024 Apr; 13(11):e2303762. PubMed ID: 38047767
[TBL] [Abstract] [Full Text] [Related]
7. Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase.
Nagaoka K; Bai X; Liu D; Cao K; Mulla J; Ji C; Chen H; Nisar MA; Bay A; Mueller W; Hildebrand G; Gao JS; Lu S; Setoyama H; Tanaka Y; Wands JR; Huang CK
Cancer Lett; 2024 Jan; 580():216493. PubMed ID: 37977350
[TBL] [Abstract] [Full Text] [Related]
8. Engineering alginate/carboxymethylcellulose scaffolds to establish liver cancer spheroids: Evaluation of molecular variances between 2D and 3D models.
Badekila AK; Pai V; Vijayan V; Kini S
Int J Biol Macromol; 2024 Jan; 254(Pt 3):128058. PubMed ID: 37956801
[TBL] [Abstract] [Full Text] [Related]
9. TuBG1 promotes hepatocellular carcinoma via atr/P53-apoptosis and cycling pathways.
Zhang Y; Wang ZZ; Han AQ; Yang MY; Zhu LX; Pan FM; Wang Y
Hepatobiliary Pancreat Dis Int; 2024 Apr; 23(2):195-209. PubMed ID: 37806848
[TBL] [Abstract] [Full Text] [Related]
10. Transradial Access for Transarterial Radioembolization (TARE) in Patients with Hepatocellular Carcinoma: Comparison with Transfemoral Access.
Yakupoğlu A; Buturak ÖSU
Cardiovasc Intervent Radiol; 2023 Oct; 46(10):1359-1364. PubMed ID: 37723353
[TBL] [Abstract] [Full Text] [Related]
11. GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective study.
Villa E; Donghia R; Baldaccini V; Tedesco CC; Shahini E; Cozzolongo R; Ascari S; Pesole PL; Coletta S; Critelli RM; Lasagni S; Schepis F; Semellini F; Giannelli G
Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37708455
[TBL] [Abstract] [Full Text] [Related]
12. Antibody designing against IIIabc junction (JIIIabc) of HCV IRES through affinity maturation; RNA-Antibody docking and interaction analysis.
Ejaz S; Paracha RZ; Ejaz S; Jamal Z
PLoS One; 2023; 18(9):e0291213. PubMed ID: 37682810
[TBL] [Abstract] [Full Text] [Related]
13. Web-Based Video Education to Improve Uptake of Influenza Vaccination and Other Preventive Health Recommendations in Adults With Inflammatory Bowel Disease: Randomized Controlled Trial of Project PREVENT.
Long MD; van Deen WK; Weisbein L; Khalil C; Appel KL; Zhang X; Chen W; Zubrod L; Maris R; Ghafari A; Dupuy T; Ha CY; Spiegel BMR; Almario CV; Melmed GY
J Med Internet Res; 2023 Aug; 25():e42921. PubMed ID: 37610821
[TBL] [Abstract] [Full Text] [Related]
14. Clinical characteristics in patients with non-alcoholic steatohepatitis in Japan: a case-control study using a 5-year large-scale claims database.
Tokutsu K; Ito K; Kawazoe S; Minami S; Fujimoto K; Muramatsu K; Matsuda S
BMJ Open; 2023 Aug; 13(8):e074851. PubMed ID: 37607790
[TBL] [Abstract] [Full Text] [Related]
15. [Causes and prognosis analysis of hyperdynamic left ventricular ejection fraction in intensive care unit patients with sepsis].
Xiong F; Yang H; Yan J; Wang C; Jin Z
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):834-838. PubMed ID: 37593862
[TBL] [Abstract] [Full Text] [Related]
16. Contrast-enhanced ultrasound liver imaging reporting and data system: clinical validation in a prospective multinational study in North America and Europe.
Lyshchik A; Wessner CE; Bradigan K; Eisenbrey JR; Forsberg F; Yi M; Keith SW; Kono Y; Wilson SR; Medellin A; Rodgers SK; Planz V; Kamaya A; Finch L; Fetzer DT; Berzigotti A; Sidhu PS; Piscaglia F;
Hepatology; 2024 Feb; 79(2):380-391. PubMed ID: 37548928
[TBL] [Abstract] [Full Text] [Related]
17. Comparing Survival After Resection, Ablation, and Radiation in Small Intrahepatic Cholangiocarcinoma.
Masoud SJ; Rhodin KE; Kanu E; Bao J; Eckhoff AM; Bartholomew AJ; Howell TC; Aykut B; Kosovec JE; Palta M; Befera NT; Kim CY; Herbert G; Shah KN; Nussbaum DP; Blazer DG; Zani S; Allen PJ; Lidsky ME
Ann Surg Oncol; 2023 Oct; 30(11):6639-6646. PubMed ID: 37436606
[TBL] [Abstract] [Full Text] [Related]
18. Long Non-coding RNA LINC00342 Promotes the Proliferation, Invasion, and Migration of Primary Hepatocellular Carcinoma Cells by Regulating the Expression of miRNA-19a-3p, miRNA-545-5p, and miRNA-203a-3p.
Yao ZX; Tu JH; Liu YL; Xue XF; Qin L
Biochem Genet; 2024 Apr; 62(2):675-697. PubMed ID: 37395850
[TBL] [Abstract] [Full Text] [Related]
19. RHNO1 disruption inhibits cell proliferation and induces mitochondrial apoptosis via PI3K/Akt pathway in hepatocellular carcinoma.
Du D; Wang S; Li T; Liu Z; Yang M; Sun L; Yuan S
Biochem Biophys Res Commun; 2023 Sep; 673():96-105. PubMed ID: 37364391
[TBL] [Abstract] [Full Text] [Related]
20. Risk of Metabolic Syndrome and Fatty liver Diseases in Gastric cancer Survivors: A Propensity Score-Matched Analysis.
Han SJ; Baik SJ; Yoon YH; Kim JH; Lee HS; Jeon S; Park H
Korean J Gastroenterol; 2023 Apr; 81(4):154-162. PubMed ID: 37096435
[TBL] [Abstract] [Full Text] [Related]
[Next]
